Roger D. Tung
2019
In 2019, Roger D. Tung earned a total compensation of $2.8M as President and Chief Executive Officer at Concert Pharmaceuticals, a 40% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $309,258 |
|---|---|
| Option Awards | $1,889,500 |
| Salary | $562,287 |
| Other | $11,304 |
| Total | $2,772,349 |
Tung received $1.9M in option awards, accounting for 68% of the total pay in 2019.
Tung also received $309.3K in non-equity incentive plan, $562.3K in salary and $11.3K in other compensation.
Rankings
In 2019, Roger D. Tung's compensation ranked 4,408th out of 13,971 executives tracked by ExecPay. In other words, Tung earned more than 68.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,408 out of 13,971 | 68th |
Division Manufacturing | 1,626 out of 5,701 | 72nd |
Major group Chemicals And Allied Products | 571 out of 2,200 | 74th |
Industry group Drugs | 482 out of 1,886 | 74th |
Industry Pharmaceutical Preparations | 365 out of 1,398 | 74th |
Source: SEC filing on April 28, 2020.
Tung's colleagues
We found two more compensation records of executives who worked with Roger D. Tung at Concert Pharmaceuticals in 2019.
News
Concert Pharmaceuticals CEO Roger Tung's 2021 pay rises 17% to $3.5M
April 26, 2022
Concert Pharmaceuticals CEO Roger Tung's 2020 pay rises 9% to $3M
April 27, 2021
Concert Pharmaceuticals CEO Roger Tung's 2019 pay falls 40% to $2.8M
April 28, 2020
Concert Pharmaceuticals CEO Roger Tung's 2018 pay jumps 34% to $4.6M
April 29, 2019